Discovery Grant Review Panels

Note: Panel lists will be updated as panel members are recruited.


Four panels of experts will review the applications submitted to the 2017 competition:

Panel A: Biology of Prostate Cancer
Studies that will develop new knowledge to improve our understanding of the biology of prostate cancer may include prostate cancer initiation (gene expression, oncogenes), tumour progression and metastasis.
 
Bharati Bapat
Chair
Lunenfeld-Tanenbaum Research Institute, Sinai Health System
Toronto, ON
Juan Ausio University of Victoria
Victoria, BC
Nicolas Bisson Chu de Quebec Research Centre
Quebec, QC
Andrei Drabovich University Health Network
Toronto, ON
Michael Hallett Concordia University
Montreal, QC
Kensuke Hirasawa Memorial University of Newfoundland
St John's, NL
Madhuri Koti Queen's University
Kingston, ON
Robert Nabi University of British Columbia
Vancouver, BC
Linda Penn University Health Network
Toronto, ON
Thomas Simmen University of Alberta
Edmonton, AB
Eva Turley London Health Sciences Centre
London, ON
Andrei Drabovich
Scientific Officer
University Health Network
Toronto, ON
Randy Baldwin
Community Representative
Niverville, MB
Jo-Anne Phillips
Community Representative
Irishtown, NB
Note: This list will be updated as panel members are recruited.


Panel B: Early Detection of Prostate Cancer
Research that aims to identify, develop and test novel prostate cancer markers and imaging methods that are helpful in detecting and/or diagnosing cancer as well as predicting the outcome or chance of recurrence.
 
Katherine Zukotynski
Chair
McMaster University
Hamilton, ON
Chantal Autexier McGill University
Montreal, QC
Laura Curiel Thunder Bay Regional Health Research Institute
Thunder Bay, ON
Ralph DaCosta University Health Network
Toronto, ON
Housheng Hansen He University Health Network
Toronto, ON
Hon Leong Lawson Health Research Institute
London, ON
Bryan Lo University of Ottawa
Ottawa, ON
Sohrab Shah BC Cancer Agency
Vancouver, BC
Bobby Shayegan McMaster University
Hamilton, ON
Amina Zoubeidi University of British Columbia
Vancouver, BC
Bill Sutherland
Community Representative
Victoria, BC
Note: This list will be updated as panel members are recruited.


Panel C: Experimental Therapeutics
This panel will review applications in the area of the discovery and development of new anti-prostate cancer treatments and includes chemotherapy, hormone therapy, radiation therapy and surgery.
 
Gregory Pond
Chair
McMaster University
Hamilton, ON
David D'Souza Western University
London, ON
Stanley Liu Sunnybrook Research Institute
Toronto, ON
Julian Lum BC Cancer Agency
Vancouver, BC
Michael Ong University of Ottawa
Ottawa, ON
Thomas Sanderson Institut national de la recherche scientifique
Quebec, QC
Jian Hui Wu McGill University
Montreal, QC
Frank Wuest University of Alberta
Edmonton, AB
Ryan Wylie McMaster University
Hamilton, ON
Geoffrey Gotto
Scientific Officer
University of Calgary
Calgary, AB
Kelly Fedorowich
Community Representative
Calgary, AB
Robert Mitchell
Community Representative
Edmonton, AB
Note: This list will be updated as panel members are recruited.


Panel D: Health systems, services, population and public health
Applications reviewed by this panel will include those studying interventions at the population level, with patients, survivors or other cohorts; epidemiological studies; research into the quality of life of those affected by prostate cancer; novel research to understand the etiology of prostate cancer; health services research related to prostate cancer.
 
Anne Katz
Chair
CancerCare Manitoba
Winnipeg, MB
Lisa Anllo Lisa Anllo, PhD LLC
Buffalo, NY, USA
Chris Blanchard Dalhousie University
Halifax, NS
Julian Kim CancerCare Manitoba
Winnipeg, MB
Girish Kulkarni University Health Network
Toronto, ON
Michael Leveridge Queen's University
Kingston, ON
Jon Tonita Saskatchewan Cancer Agency
Regina, SK
Gabriela Ilie
Scientific Officer
Dalhousie University
Halifax, NS
Kelly Keen
Community Representative
Edmonton, AB
Vince Schiralli
Community Representative
Vancouver, BC
Note: This list will be updated as panel members are recruited.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive